Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Advanced Proteome Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | -2.660% | -2.825% | -7.527% | 9.554% | 3.614% | -1.714% | -62.811% |
| Northwest Biotherapeutics Inc. | 0.000% | 36.364% | 12.500% | -7.216% | -12.621% | -59.641% | -83.636% |
| Achieve Life Sciences Inc. | 0.890% | 4.587% | 11.765% | 171.429% | 54.054% | 18.750% | -5.785% |
News
Spectral AI Q2 Earnings Call Highlights
Key Points
- Interested in Spectral AI, Inc.? Here are five stocks we like better.
- FDA clearance is shifting Spectral AI toward commercialization: The company plans a disciplined U.S. and
NORMA Group Q2 Earnings Call Highlights
Key Points
- Interested in NORMA Group SE? Here are five stocks we like better.
- Profitability improved despite weak automotive demand: Q2 adjusted EBIT rose to EUR 7.6 million from EUR 2.3
ePropelled to Increase Manufacturing Footprint with $60 Million in U.S. Government Funding to Strengthen U.S. Drone Propulsion Supply Chain
Expansion Increases Manufacturing Capacity by 4X and Positions ePropelled as a Leading Domestic Supplier of Advanced Dual-Use Electric Propulsion Systems
COVENTRY, UK / ACCESS Newswire /
